Oncogene - Table of Contents alert Volume 31 Issue 15

TABLE OF CONTENTS Volume 31, Issue 15 (April 2012) In this issue Review Original Articles Short Communication Also new AOP Advertisement tONCO™ has all of the tools you need, including: * Spontaneous tumor models for breast & colon cancer. * Tumor tissues or cohorts of allografted animals. * Patient-derived xenograft models. * Bioluminescent imaging technologies. Learn more. Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Oncogenesis Brought to you by the editorial team of Oncogene, Oncogenesis is a peer-reviewed online journal that publishes full-length papers exploring the molecular basis of cancer and related phenomena. It seeks to promote diverse and integrated areas of molecular biology, cell biology, oncology, and genetics. Submit to Oncogenesis and contribute to this new and exciting journal!   Review Top Molecular mechanisms of cisplatin resistance L Galluzzi, L Senovilla, I Vitale, J Michels, I Martins, O Kepp, M Castedo and G Kroemer Oncogene 2012 31: 1869-1883; advance online publication, September 5, 2011; 10.1038/onc.2011.384 Abstract | Full Text Original Articles Top Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases T Papagiannakopoulos, D Friedmann-Morvinski, P Neveu, J C Dugas, R M Gill, E Huillard, C Liu, H Zong, D H Rowitch, B A Barres, I M Verma and K S Kosik Oncogene 2012 31: 1884-1895; advance online publication, August 29, 2011; 10.1038/onc.2011.380 Abstract | Full Text Introduction of SV40ER and hTERT into mammospheres generates breast cancer cells with stem cell properties A N Paranjape, T Mandal, G Mukherjee, M V Kumar, K Sengupta and A Rangarajan Oncogene 2012 31: 1896-1909; advance online publication, August 29, 2011; 10.1038/onc.2011.378 Abstract | Full Text MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer M V Geraldo, A S Yamashita and E T Kimura Oncogene 2012 31: 1910-1922; advance online publication, August 29, 2011; 10.1038/onc.2011.381 Abstract | Full Text Oncogenic YAP promotes radioresistance and genomic instability in medulloblastoma through IGF2-mediated Akt activation A Fernandez-L, M Squatrito, P Northcott, A Awan, E C Holland, M D Taylor, Z Nahlé and A M Kenney Oncogene 2012 31: 1923-1937; advance online publication, August 29, 2011; 10.1038/onc.2011.379 Abstract | Full Text Disabling the mitotic spindle and tumor growth by targeting a cavity-induced allosteric site of survivin A Berezov, Z Cai, J A Freudenberg, H Zhang, X Cheng, T Thompson, R Murali, M I Greene and Q Wang Oncogene 2012 31: 1938-1948; advance online publication, September 5, 2011; 10.1038/onc.2011.377 Abstract | Full Text AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancy M V Astle, K M Hannan, P Y Ng, R S Lee, A J George, A K Hsu, Y Haupt, R D Hannan and R B Pearson Oncogene 2012 31: 1949-1962; advance online publication, September 12, 2011; 10.1038/onc.2011.394 Abstract | Full Text Stabilization of phenotypic plasticity through mesenchymal-specific DNA hypermethylation in cancer cells Y Kurasawa, K Kozaki, A Pimkhaokham, T Muramatsu, H Ono, T Ishihara, N Uzawa, I Imoto, T Amagasa and J Inazawa Oncogene 2012 31: 1963-1974; advance online publication, August 29, 2011; 10.1038/onc.2011.373 Abstract | Full Text Regulation of APC/CCdc20 activity by RASSF1A–APC/CCdc20 circuitry C Chow, N Wong, M Pagano, S W-M Lun, K-I Nakayama, K Nakayama and K-W Lo Oncogene 2012 31: 1975-1987; advance online publication, August 29, 2011; 10.1038/onc.2011.372 Abstract | Full Text Short Communication Top Silencing of Kruppel-like factor 2 by the histone methyltransferase EZH2 in human cancer H Taniguchi, F V Jacinto, A Villanueva, A F Fernandez, H Yamamoto, F J Carmona, S Puertas, V E Marquez, Y Shinomura, K Imai and M Esteller Oncogene 2012 31: 1988-1994; advance online publication, September 5, 2011; 10.1038/onc.2011.387 Abstract | Full Text Advertisement Call for papers! Submit your best work in cancer research, including mechanisms of cellular oncogene activation, structure and function of encoded proteins, DNA and RNA tumor viruses and all other aspects of oncogene structure and function. Our online submission process is easy and can assist you in becoming part of this distinguished journal. Visit our Author page to learn about the benefits of publishing in the Journal and for guidelines on how to submit your paper.   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.